Clinical Trial Update: An Efficacy and Safety Study of Corifollitropin Alfa (MK-8962) in Contrast to Recombinant FSH for Use in Controlled Ovarian Stimulation of Indian Women (P07056, Also Known as MK-8962-029) [Phase 3]

View source ↗

Summary

Phase 3 trial of corifollitropin alfa (MK-8962) versus recombinant FSH for controlled ovarian stimulation in Indian women was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Corifollitropin alfa (Corifollitropin alfa)

Snippet

Sponsor: Organon and Co | Conditions: Infertility | Phase 3 | Status: WITHDRAWN